Corteva (NYSE:CTVA) Issues Quarterly Earnings Results

Corteva (NYSE:CTVA) posted its earnings results on Wednesday. The company reported ($0.79) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.81), Zacks reports. Corteva had a return on equity of 10.18% and a net margin of 5.66%. Corteva updated its FY 2026 guidance to 0.760-0.800 EPS.

Corteva Stock Performance

CTVA stock traded up $0.03 on Wednesday, hitting $12.20. The company had a trading volume of 13,222,209 shares, compared to its average volume of 8,034,034. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a 12-month low of $11.24 and a 12-month high of $90.97. The stock has a market cap of $8.14 billion, a price-to-earnings ratio of 8.08, a P/E/G ratio of 1.69 and a beta of 0.58. The stock’s 50-day simple moving average is $41.93 and its 200 day simple moving average is $70.50.

Corteva Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be issued a $0.05 dividend. This is a decrease from Corteva’s previous quarterly dividend of $0.18. This represents a $0.20 annualized dividend and a yield of 1.6%. The ex-dividend date is Tuesday, December 1st. Corteva’s dividend payout ratio is 13.25%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CTVA. Weiss Ratings cut shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. KeyCorp raised Corteva from a “sector weight” rating to an “overweight” rating and set a $17.00 target price on the stock in a research note on Wednesday, October 7th. Zacks Research downgraded Corteva from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 6th. Citigroup lifted their price target on Corteva from $86.00 to $91.00 and gave the stock a “neutral” rating in a research report on Thursday, September 17th. Finally, Bank of America upped their price target on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $60.59.

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.